NAV1/13/2017 Chg.+0.3700 Type of yield Investment Focus Investment company
398.2000USD +0.09% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - 2.88 4.05 5.17 7.56 0.15 5.07 -10.89 6.76 0.37 -
2010 1.37 2.88 4.90 -1.65 -12.38 -3.44 3.02 -2.03 12.01 6.40 -4.72 7.46 +12.10%
2011 -2.91 0.16 0.92 8.13 0.01 -0.79 -2.10 -13.30 -7.02 5.96 0.39 2.95 -9.00%
2012 13.39 1.68 3.30 0.35 -0.58 3.74 3.80 1.95 5.67 -8.59 4.96 -0.58 +31.48%
2013 7.49 1.65 7.76 9.32 2.92 -3.92 14.70 -2.77 9.09 -3.21 8.20 0.98 +63.75%
2014 9.96 6.60 -10.90 -4.05 2.82 8.50 -1.15 11.32 -1.20 10.11 2.59 -0.70 +36.33%
2015 7.89 5.71 0.50 -3.89 9.81 -0.41 2.01 -11.59 -12.36 9.46 2.34 0.90 +7.63%
2016 -23.11 -5.21 4.49 3.99 3.33 -9.40 13.18 -2.83 2.91 -14.05 8.71 -3.95 -24.69%
2017 7.86 - - - - - - - - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 26.79% 27.02% 30.17% 28.64% 25.36%
Sharpe ratio 55.43 0.45 -0.01 0.16 0.75
Best month +7.86% +13.18% +13.18% +13.18% +14.70%
Worst month -3.95% -14.05% -23.11% -23.11% -23.11%
Maximum loss -3.02% -20.50% -20.50% -42.26% -42.26%
Outperformance +4.75% - -2.49% +2.48% +46.85%
 
All quotes in USD

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 421.9200 +0.07% +15.49%
BB Adamant Biotech I EUR reinvestment 531.8400 +2.18% +48.40%
BB Adamant Biotech I CHF reinvestment 375.5500 +0.11% +29.21%
BB Adamant Biotech B USD reinvestment 398.2000 -0.69% +12.94%
BB Adamant Biotech B CHF reinvestment 352.5400 -0.64% +26.36%
BB Adamant Biotech B EUR reinvestment 500.0900 +1.41% +45.13%

Performance

YTD  
+7.86%
6 Months  
+5.74%
1 Year
  -0.69%
3 Years  
+12.94%
5 Years  
+135.22%
Since start  
+218.56%
Year
2016
  -24.69%
2015  
+7.63%
2014  
+36.33%
2013  
+63.75%
2012  
+31.48%
2011
  -9.00%
2010  
+12.10%